Published on:

Study: Risk of Lung Defects in Newborns Rises with Antidepressant Use

A new study published this month in the medical journal BMJ found that a newborn’s risk of persistent pulmonary hypertension (PPH) increases if the mother uses antidepressants during the final trimester of her pregnancy. If a prescription drug negatively impacted your health or your child’s health, Vista attorney Zev Rubinstein can pursue a product liability case on your behalf.

PPH occurs when blood flow in the lungs is interrupted due to the failure of the newborn’s circulatory system to begin functioning independently outside of the womb. This condition can lead to symptoms ranging from breathing problems to dangerously low oxygen levels in the blood.

Unfortunately, PPH isn’t the only serious birth defect that research has linked to the use of selective serotonin reuptake inhibitors (SSRIs) to treat depression during pregnancy. Prenatal SSRI exposure has been found to increase risk of the following in newborns:

  • Low birth weight
  • Heart defects
  • Malformations of the limbs, mouth or face
  • Incomplete development of the spinal cord or brain (anencephaly)
  • Premature fusion of bones in the skull (craniosynostosis)

Drug manufacturers are legally obligated to provide warnings about the potential risks medication can have for mothers and their unborn children. When companies fail to provide adequate warning and a child is born with, or tragically passes away from, a serious birth defect, the family might be entitled to compensation for medical bills, exceptional care costs, pain and suffering and other damages.

If you or someone you love suffered severe injury because of a dangerous drug or other defective product, please contact the Rubinstein Law Group or call 855-365-9955 today to schedule your initial consultation. Mr. Rubinstein is proud to represent clients in or around Vista, California, and the surrounding areas.